33^rd World Congress on Cardiology & Heart Diseases August 23-24, 2021 Singapore City,Singapore

The previous head of the cardiology department, Faculty of Medicine, Alexandria University, Egypt Published 33 papers listed in Google Scholar, 40 other papers published not available on the internet. Reviewer in National council for the promotion of professors in cardiology and critical care, reviewer of some journals, grader of abstracts of the European Society of Cardiology conference, and EHRA European Heart Rhythm Association conference. Worked in ablation and device implantation in Alexandria Faculty of Medicine Chairperson or speaker in Many conferences inside and outside Egypt

Electrophysiology, Echocardiography, Pacemaker therapy

Rui Manuel de Sousa Sequeira Antunes de Almeida is the Board Member of the Paraná’ Society of Cardiovascular Surgery, since 2002, and became its President (2006- 08). He was elected as a President of the South Brazilian’ Society of Cardiovascular Surgery (2007-09), a Member of the Board of the Brazilian’ Society of Cardiovascular Surgery (2009-2010), President of the Board (2011-2013) and President of the Endovascular Department of the Brazilian’ Society of Cardiovascular Surgery (2011-2013), Scientific Director of the Brazilian’ Society of Cardiovascular Surgery (2014-15) and Vice-President for the period of 2016-17. He has published more than 100 papers in peer reviewed national and international medical journals and presented more than 250 papers in scientific meetings. He also served as the Editorial Board Member of 10 international journals and five Brazilian journals.

Cardiovascular Surgery

Assistant Professor Clinical Hospital Sveti Duh & Josip Juraj Strossmayer University of Osijek Croatia

Cardiology

Manuela Stoicescu is the Consultant Internal Medicine, PhD, Assistant professor of University of Oradea, Faculty of Medicine and Pharmacy, Medical Disciplines Department, Romania.

Internal Medicine

Camelia Nicolae is an Assistant Professor in Internal Medicine and Cardiology Department at Carol Davila University of Medicine and Pharmacy, Bucharest. She has been working in the Coronary and Intensive Care Unit. In clinical activity, she was interested in diagnosis and treatment of acute coronary syndrome, acute cardiac failure and pulmonary thromboembolism. She had a special pre-occupation about ventricular remodelling post-acute myocardial infarction, which was reflected in her Doctoral thesis.

Coronary ischemic disease

Dr. Robert Roberts completed his undergraduate (Memorial University), Medical school (Dalhousie University) and training in cardiology (University of Toronto) in Canada. He was recruited to Washington University in St. Louis as Director of the Coronary Care unit (1973-1982). In 1982 he was recruited to Baylor College of Medicine in Houston as Chief of Cardiology where he served for 23 years and was recruited as President and CEO of the University of Ottawa Heart Institute (UOHI) where he completed two 5 year terms (2004 to 2014). He developed the first quantitative assay for MBCK, followed by a radioimmunoassay. MBCK was used as the gold standard to diagnose heart attacks for three decades. He discovered several genes for the familial cardiomyopathies, including the first gene for atrial fibrillation, WPW Syndrome and CAD (9p21) along with co-discoverer of over 90 genetic risk variants predisposing to CAD and 95 genetic variants regulating plasma lipids. As a pioneer of molecular cardiology, he edited the first textbook on molecular cardiology. Dr. Roberts is recognized as a leader in the research and practice of cardiology worldwide. Dr. Roberts for 25 years has been associate Editor of Hurst The Heart, a leading textbook in cardiology. Dr. Roberts is Editor in Chief of Current Opinion in Cardiology, Chief Guest Editor of JACC BTS, Genomics Section Editor for JACC, Associate Editor of Cardiology Today and on the editorial board of 18 other journals. In recognition of his scientific contributions (over 900 publications). Dr. Roberts has had a distinguished and prolific international career as a Cardiologist, Educator, Scientist and spokesman having lectured throughout the world including several prestigious presentations: Plenary addresses of the American College of Cardiology, (Simon Dack Lectureship), the Japanese College of Cardiology, the Japanese College of Circulation, the Australian and New Zealand Heart Association (Hall Lecture), the Canadian Cardiovascular Society, Indonesian Heart Society and the International Academy of Cardiology. In 2013 he addressed The Royal Canadian Institute for the advancement of science. Under Dr. Roberts leadership, the University of Ottawa Heart Institute (UOHI) flourished. He founded and directed The Ruddy Canadian Cardiovascular Genetics Centre, and established The Research Methods Centre.

Coronary Artery Disease, Molecular Biology and Genetics to Heart Disease and cardiovascular genetics, Molecular cardiology

Dr. Naranjan S Dhalla is a Distinguished Professor, Max Rady College of Medicine, University of Manitoba. He served for 19 years as Founding Director of the Institute of Cardiovascular Sciences at the St. Boniface Hospital, Winnipeg, Canada. He has been working in the field of Experimental Cardiology with a focus on pathophysiology and pharmacology of cardiac dysfunction and he was one of the first investigators to identify membrane defects during the development of heart disease. He has published 819 full length papers, which are cited more than 26,702 times in addition to editing 56 books, and training 163 fellows and graduate students in biochemical and molecular medicine. As Secretary General and then President during 1972-1996, he developed the International Society for Heart Research for promoting cardiovascular research. He has been the Executive Director of the International Academy of Cardiovascular Sciences, which he founded in 1996 for promoting the cardiovascular education and prevention of heart disease; he was elected as Honorary Life President in 2016 of this organization. For the past 32 years, he has been Editor-in-Chief of an international journal "Molecular and Cellular Biochemistry." He has has received 199 honours and awards, including 6 Honorary Doctorate Degrees and 4 Honoris Causa Professorships from different Institutions. He has been invited to give 521 talks at various conferences and institutions around the globe. He is Fellow of the Royal Society of Canada, Member of the Order of Canada, Member of the Order of Manitoba and Inductee into the Winnipeg Citizens Hall of Fame.

Experimental Cardiology,Cardiovascular Sciences, congestive heart failure, cardiomyopathy

Marco Picichè completed his Graduation in Medicine from University of Florence in 1995 and Cardiac Surgery Residency at Tor Vergata University of Rome in 2000, both summa cum laude. He held regular teaching appointments at the University of Montpellier-School of Medicine; obtained certification by the French board in Cardiac Surgery (Paris, 2007); earned his Research Master’s in Surgical Science (Paris, 2007) and; received a University Diploma in Vascular Surgery (Paris, 2007). In Canada, he authored a research project on the occlusion of the internal mammary arteries as an alternative method of myocardial blood supply. In September 2011, he received PhD degree in Therapeutic Innovations from Paris-Sud University. He is the Editor in Chief of the book: “Dawn and Evolution of Cardiac Procedures: Research Avenues in Cardiac Surgery and Interventional Cardiology” (Springer-Verlag publishing house, September 2012). He patented a new surgical instrument. Currently, he is a Cardiac Surgeon in Italy.

Cardiac Surgery, Vascular Surgery

Dr. Lerakis is a Professor of Medicine in the Division of Cardiology at Emory University School of Medicine. He is also a Professor of Radiology and Imaging Sciences at Emory University. He is an Adjunct Professor of Biomedical Engineering at Georgia Institute of Technology and Emory University. Dr. Lerakis is the Director of Interventional Echo and Cardiac MRI at Emory University Hospital and Emory Clinic. He received his M.D. degree from the Medical School of Athens (Greece) in 1988. He continued on doing clinical research in Nuclear Cardiology atMount Sinai Medical Center in New York City. Subsequently, he did his Internal Medicine training at the Presbyterian Medical Center, University of Pennsylvania, in Philadelphia from 1991 to 1994 and completed his Fellowship in Critical Care Medicine at Brown University from 1994 to 1995. He went on to complete his Cardiology Fellowship at the University of Texas Medical Branch in Galveston, Texas from 1995 to 1998 and then did one year of Echocardiography Fellowship at Emory University from 1998 to 1999. After his Echocardiography Fellowship, he has stayed on as Faculty in the Division of Cardiology practicing clinical and non-invasive cardiology.

Correlation of different non-invasive modalities in the diagnosis of Coronary Artery Disease,use of Echocardiography for guiding interventional procedures, device deployment and Transcatheter Valvular therapies for Structural and Valvular Heart Diseases.

Marco Picichè (MD, Ph.D.) graduated with a degree in medicine from the University of Florence in 1995 and completed his cardiac surgery residency at the Tor Vergata University of Rome in 2000, both summa cum laude. He held regular teaching appointments at the university of Montpellier school of medicine, obtained certification by the French Board in cardiac surgery (Paris, 2007), earned his research master in surgical science (Paris, 2007), and received a university diploma in vascular surgery (Paris, 2007). In May 2009 he had the honor of opening the 44th Congress of the European Society for Surgical Research with a lecture on ‘‘The history of surgical research.’’ In September 2011 he received a doctor of philosophy (Ph.D.) in therapeutic innovations from Paris-Sud University. He is the Editor in Chief of the book : « Dawn and evolution of cardiac procedures : research avenues in cardiac surgery and interventional cardiology » (Springer-Verlag publishing house, September 2012). He patented a new surgical instrument. Currently he is a cardiac surgeon in Italy.

Cardiac surgery, Interventional cardiology

Dr Avanzas graduated in Medicine at Universidad de Navarra, Pamplona, Spain. He completed Senior House Officer posts and registrar training in Cardiology at Gregorio Marañón Hospital in Madrid, Spain. He took up a Spanish Heart Foundation Research Fellowship at Coronary Artery Research Unit, St. George´s Hospital Medical School in London and some months after that he was appointed as Associate Research Investigator of the Cardiovascular Biology Research Centre at St. George´s Hospital in London. He was also appointed as Consultant Cardiologist in Gregorio Marañón Hospital, Madrid, Spain and he also took up an Interventional Cardiology Fellowship in Hospital Universitario Central de Asturias, Oviedo, Spain. He is now Consultant in Invasive Cardiology in this Hospital. His major interests currently are in the field of coronary artery disease and inflammation, markers of myocardial ischemia and interventional cardiology, particularly antiplatelet therapies and percutaneous valve replacement. He is Fellow of the European Society of Cardiology (working groups: Atherosclerosis, European Association of Percutaneous Cardiovascular Interventions and Acute Cardiovascular Care Association) and member of European Society of Atherosclerosis, International Society of Cardiovascular Pharmacotherapy (Spanish Gobernor and WEB editor), Spanish Society of Cardiology and several regional cardiac societies. Dr Avanzas is author of more than 170 peer-reviewed articles and invited contributions (h-index=19) and Associate Editor of Revista Española de Cardiología (IF:3.3), Heart India and Bio Med Research International (IF: 2,7). He belongs to several scientific journal Editorial Boards (American Journal of Cardiology, World Journal of Translational Medicine, ISRN Cardiology, BioMed Research International, World Journal of Meta-Analysis, Advances in Medicine…). He is a frequent reviewer of more than 30 Cardiology journals and is also involved in teaching medical students and postgraduate teaching. Dr Avanzas is a frequent speaker at national and international meetings.

Coronary artery disease and inflammation, Markers of myocardial ischemia and interventional cardiology, Antiplatelet therapies and Percutaneous valve replacement

Guy H Fontaine has made 17 original contributions in the design and the use of the first cardiac pace makers in the early 60s. He has serendipitously identified ARVD during his contributions to antiarrhythmic surgery in the early 70s. He has developed the technique of Fulguration to replace surgery in the early 80s (technique used during 30 years in Paris). He has been one of the 216 individuals who have made a significant contribution to the study of cardiovascular disease since the 14th century, one of the 500 greatest geniuses of the 21th Century (USA Books), one of the 100 Life Time Achievement (UK Book). He has more than 900 publications including 201 chapters in text books. He is the reviewer of 26 scientific journals both in basic and clinical science. He served as a member of the Editorial Board of Circulation for 5 years, after reviewing articles for this journal during decades. He has given 11 master lectures of 90 minutes each in inland China in 2014. He has recently developed new techniques of hypothermia for brain protection in OHCA and Stroke. This technique has been fortuitously used after resuscitation of his wife at home in June 2011 with absolutely no neurologic deficit despite 6 minutes of no flow. He has also invented a high-tech device which can be considered the ultimate in palliative care by preventing unexpectedly awaking after ordinary sleep. This device was mostly designed for major neurologic disorders. To know more about him introduce his full name on Google “Guy Hugues Fontaine”. His main lectures for the year 2016 have been in Cardiology and Neurology in: London, Dubai, Berlin, Baltimore, Philadelphia, Las Vegas, Tucson, Miami and Dubai again.

Antiarrhythmic surgery, Cardiovascular Disease, Cardiac Pace Makers

Giovanni Fazio, MD was born in Ragusa on June 11st, 1978. He graduated from secondary school in Scientific Studies with 60 ot 60 at “Liceo Scientifico Galileo Galilei” in Modica. He received his Medical Degree with 110 out of 110 cum laude at University of Palermo on July 26th, 2002. He became Specialist in Cardiology at the same University on November 30th, 2006. In 2011 he finished his PhD program on Diagnostic science and biomedical technology. He successfully completed a Secondary level Master in Project Management at University of Palermo within the F.I.O.R.I. project. Dr. Fazio is certified as BLS-D instructor by Italian Society of Cardiology (SIC) and accredited as echocardiographist by the Italian Society of Cardiovascular Echography (SIEC) He is the Head of the Deparment of Medicine at “Casa di Cure Triolo-Zancla” which includes the following units: internal medicine, cardiology, angiology and long-term care as well as the cardiologist for all these units. He is also the Deputy Health-director of “Casa di Cure Triolo-Zancla”. Responsible for the Cardiology specialty at “Poliambulatorio” in Porticello and “Poliambulatorio Riabiliter” in Palermo. He also works as both cardiologist and sports medicine physician at many centers and he is member of Italian Federation of Sport Medicine (FMSI). He is also experienced in pediatric cardiology as certified at Bambino Gesù Hospital in Rome. He is member of 10 Scientific societies and of the Task Force of pediatric arrhythmology of the Italian Society AIAC. Dr. Fazio has also organized many conference on cardiology for multiple Italian societies (i.e. SICsport, SICOA, SIC, SIEC).

electrocardiogram, echocardiogram, vascular echocolordoppler, cardiac and pressure Holter, ergometry, myocardial scintigraphy, cardiac magnetic resonance, tilt test, transesophageal electrophysiological studies